Patient Square Capital »

Arcus Biosciences Incorporated shares owned by Patient Square Capital

Quarter-by-quarter ownership of Arcus Biosciences Incorporated (RCUS) shares owned by Patient Square Capital from 13F filings

Historical chart of Patient Square Capital investment in Arcus Biosciences Incorporated

Tip: Access up to 7 years of quarterly data

All positions including Arcus Biosciences Incorporated held by Patient Square Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Arcus Biosciences Incorporated by Patient Square Capital

Quarter filed Position value Share count Share price at filing
2025-12-31 $4.1M 170k 23.83

More positions owned by Patient Square Capital

Roivant Sciences SHS (ROIV)
Insmed Com Par $.01 (INSM)
Mirum Pharmaceuticals (MIRM)
Argenx Se Sponsored Adr (ARGX)
Beone Medicines Sponsored Ads (ONC)
Abivax Sa Sponsored Ads (ABVX)
Pharvaris N V (PHVS)
Eyepoint Com New (EYPT)
Terns Pharmaceuticals (TERN)
Celcuity (CELC)
Cogent Biosciences (COGT)
Kymera Therapeutics (KYMR)
Liquidia Corporation Com New (LQDA)
Dbv Technologies S A Sponsored Ads (DBVT)
Allogene Therapeutics (ALLO)

View all positions for Patient Square Capital

Top funds holding Arcus Biosciences Incorporated

Gilead Sciences
BlackRock
Vanguard Group
Suvretta Capital Management
State Street Corporation
Woodline Partners
Marshall Wace
Point72 Asset Management
Siren
FMR
Fisher Investments
Caption Management
Geode Capital Management
Balyasny Asset Management
Bnp Paribas Investment Partners

View all funds holding Arcus Biosciences Incorporated